Showing 1 - 1 of 1 Colon and Colorectal Cancer

Status: Enrolling

Investigator: Maen Abdelrahim

Study Coordinator:


This randomized phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread to other places in ... Read more >